Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2005 1
2006 1
2007 3
2008 3
2009 1
2010 1
2011 1
2012 2
2016 2
2019 4
2020 1
2021 3
2022 4
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

25 results

Results by year

Filters applied: . Clear all
Page 1
Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial.
Gerstein HC, Colhoun HM, Dagenais GR, Diaz R, Lakshmanan M, Pais P, Probstfield J, Riesmeyer JS, Riddle MC, Rydén L, Xavier D, Atisso CM, Dyal L, Hall S, Rao-Melacini P, Wong G, Avezum A, Basile J, Chung N, Conget I, Cushman WC, Franek E, Hancu N, Hanefeld M, Holt S, Jansky P, Keltai M, Lanas F, Leiter LA, Lopez-Jaramillo P, Cardona Munoz EG, Pirags V, Pogosova N, Raubenheimer PJ, Shaw JE, Sheu WH, Temelkova-Kurktschiev T; REWIND Investigators. Gerstein HC, et al. Lancet. 2019 Jul 13;394(10193):121-130. doi: 10.1016/S0140-6736(19)31149-3. Epub 2019 Jun 9. Lancet. 2019. PMID: 31189511 Clinical Trial.
Dulaglutide and renal outcomes in type 2 diabetes: an exploratory analysis of the REWIND randomised, placebo-controlled trial.
Gerstein HC, Colhoun HM, Dagenais GR, Diaz R, Lakshmanan M, Pais P, Probstfield J, Botros FT, Riddle MC, Rydén L, Xavier D, Atisso CM, Dyal L, Hall S, Rao-Melacini P, Wong G, Avezum A, Basile J, Chung N, Conget I, Cushman WC, Franek E, Hancu N, Hanefeld M, Holt S, Jansky P, Keltai M, Lanas F, Leiter LA, Lopez-Jaramillo P, Cardona Munoz EG, Pirags V, Pogosova N, Raubenheimer PJ, Shaw JE, Sheu WH, Temelkova-Kurktschiev T; REWIND Investigators. Gerstein HC, et al. Lancet. 2019 Jul 13;394(10193):131-138. doi: 10.1016/S0140-6736(19)31150-X. Epub 2019 Jun 9. Lancet. 2019. PMID: 31189509 Clinical Trial.
Renal denervation: dark past, bright future?
Heradien M, Mahfoud F, Hettrick D, Brink P. Heradien M, et al. Cardiovasc J Afr. 2019 Sep/Oct;30(5):290-296. doi: 10.5830/CVJA-2019-045. Cardiovasc J Afr. 2019. PMID: 31746943 Free PMC article. Review.
Percutaneous left atrial appendage occlusion in South Africa.
Dippenaar AP, Van der Bijl P, Heradien MJ, Saaiman A. Dippenaar AP, et al. Among authors: heradien mj. S Afr Med J. 2021 Jun 30;111(7):13337. doi: 10.7196/SAMJ.2021.v111i7.15536. S Afr Med J. 2021. PMID: 34382540 No abstract available.
Renal Denervation in High-risk Patients with Hypertension.
Heradien MJ, van der Bijl P, Brink PA. Heradien MJ, et al. Heart Int. 2019 Dec 2;13(2):12-16. doi: 10.17925/HI.2019.13.2.12. eCollection 2019. Heart Int. 2019. PMID: 36274824 Free PMC article. Review.
Renal denervation prevents subclinical atrial fibrillation in patients with hypertensive heart disease: Randomized, sham-controlled trial.
Heradien M, Mahfoud F, Greyling C, Lauder L, van der Bijl P, Hettrick DA, Stilwaney W, Sibeko S, Jansen van Rensburg R, Peterson D, Khwinani B, Goosen A, Saaiman JA, Ukena C, Böhm M, Brink PA. Heradien M, et al. Heart Rhythm. 2022 Nov;19(11):1765-1773. doi: 10.1016/j.hrthm.2022.06.031. Epub 2022 Jun 30. Heart Rhythm. 2022. PMID: 35781044 Clinical Trial.
Renal denervation in South Africa.
Heradien MJ, Van der Bijl P, Brink PA. Heradien MJ, et al. S Afr Med J. 2020 Jan 29;110(2):12841. doi: 10.7196/SAMJ.2020.v110i2.14521. S Afr Med J. 2020. PMID: 32657674 No abstract available.
25 results